Literature DB >> 31729464

CUL4B negatively regulates Toll-like receptor-triggered proinflammatory responses by repressing Pten transcription.

Yu Song1, Peishan Li1, Liping Qin1, Zhiliang Xu1, Baichun Jiang1, Chunhong Ma2, Changshun Shao3, Yaoqin Gong4.   

Abstract

Toll-like receptors (TLRs) play critical roles in innate immunity and inflammation. The molecular mechanisms by which TLR signaling is fine-tuned remain to be completely elucidated. Cullin 4B (CUL4B), which assembles the CUL4B-RING E3 ligase complex (CRL4B), has been shown to regulate diverse developmental and physiological processes by catalyzing monoubiquitination for histone modification or polyubiquitination for proteasomal degradation. Here, we identified the role of CUL4B as an intrinsic negative regulator of the TLR-triggered inflammatory response. Deletion of CUL4B in macrophages increased the production of proinflammatory cytokines and decreased anti-inflammatory cytokine IL-10 production in response to pathogens that activate TLR3, TLR4, or TLR2. Myeloid cell-specific Cul4b knockout mice were more susceptible to septic shock when challenged with lipopolysaccharide, polyinosinic-polycytidylic acid or Salmonella typhimurium infection. We further demonstrated that enhanced TLR-induced inflammatory responses in the absence of CUL4B were mediated by increased GSK3β activity. Suppression of GSK3β activity efficiently blocked the TLR-triggered increase in proinflammatory cytokine production and attenuated TLR-triggered death in Cul4b mutant mice. Mechanistically, CUL4B was found to negatively regulate TLR-triggered signaling by epigenetically repressing the transcription of Pten, thus maintaining the anti-inflammatory PI3K-AKT-GSK3β pathway. The upregulation of PTEN caused by CUL4B deletion led to uncontrolled GSK3β activity and excessive inflammatory immune responses. Thus, our findings indicate that CUL4B functions to restrict TLR-triggered inflammatory responses through regulating the AKT-GSK3β pathway.

Entities:  

Keywords:  CUL4B; TLR signaling; Transcriptional repression

Mesh:

Substances:

Year:  2019        PMID: 31729464      PMCID: PMC8026642          DOI: 10.1038/s41423-019-0323-0

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN: 1672-7681            Impact factor:   11.530


  50 in total

Review 1.  Toll-like receptors: critical proteins linking innate and acquired immunity.

Authors:  S Akira; K Takeda; T Kaisho
Journal:  Nat Immunol       Date:  2001-08       Impact factor: 25.606

Review 2.  Toll-like receptor signalling.

Authors:  Shizuo Akira; Kiyoshi Takeda
Journal:  Nat Rev Immunol       Date:  2004-07       Impact factor: 53.106

Review 3.  Pattern recognition receptors and inflammation.

Authors:  Osamu Takeuchi; Shizuo Akira
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

Review 4.  Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics.

Authors:  Richard S Jope; Christopher J Yuskaitis; Eléonore Beurel
Journal:  Neurochem Res       Date:  2006-08-30       Impact factor: 3.996

Review 5.  The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling.

Authors:  Luke A J O'Neill; Andrew G Bowie
Journal:  Nat Rev Immunol       Date:  2007-05       Impact factor: 53.106

Review 6.  Newly described pattern recognition receptors team up against intracellular pathogens.

Authors:  Petr Broz; Denise M Monack
Journal:  Nat Rev Immunol       Date:  2013-07-12       Impact factor: 53.106

Review 7.  Toll-like receptors and their crosstalk with other innate receptors in infection and immunity.

Authors:  Taro Kawai; Shizuo Akira
Journal:  Immunity       Date:  2011-05-27       Impact factor: 31.745

Review 8.  Toll-like receptors and adaptor molecules in liver disease: update.

Authors:  Ekihiro Seki; David A Brenner
Journal:  Hepatology       Date:  2008-07       Impact factor: 17.425

9.  Insulin reduces the multiple organ injury and dysfunction caused by coadministration of lipopolysaccharide and peptidoglycan independently of blood glucose: role of glycogen synthase kinase-3beta inhibition.

Authors:  Laura Dugo; Marika Collin; David A Allen; Oliver Murch; Simon J Foster; Muhammad M Yaqoob; Christoph Thiemermann
Journal:  Crit Care Med       Date:  2006-05       Impact factor: 7.598

Review 10.  Targeting toll-like receptors: promising therapeutic strategies for the management of sepsis-associated pathology and infectious diseases.

Authors:  Athina Savva; Thierry Roger
Journal:  Front Immunol       Date:  2013-11-18       Impact factor: 7.561

View more
  7 in total

1.  Aberrant expression of miR-199a in newborns with hypoxic-ischemic encephalopathy and its diagnostic and prognostic significance when combined with S100B and NSE.

Authors:  Min Li; Mei Ye; Guangyun Zhang
Journal:  Acta Neurol Belg       Date:  2020-06-12       Impact factor: 2.396

2.  ACK1 Contributes to the Pathogenesis of Inflammation and Autoimmunity by Promoting the Activation of TLR Signaling Pathways.

Authors:  Lina Jing; Xin Zhang; Dong Liu; Yonghong Yang; Huabao Xiong; Guanjun Dong
Journal:  Front Immunol       Date:  2022-05-20       Impact factor: 8.786

3.  CUL4B is a Potential Novel Prognostic Biomarker and is Correlated with Immune Infiltrates in Malignant Pleural Mesothelioma.

Authors:  Lu Liu; Ruting Hui; Tianyang Zeng; Xuetao Yang; Qingchen Wu; Tao Yang
Journal:  Int J Gen Med       Date:  2022-05-03

4.  Identification of different proteins binding to Na, K-ATPase α1 in LPS-induced ARDS cell model by proteomic analysis.

Authors:  Xu-Peng Wen; Guo Long; Yue-Zhong Zhang; He Huang; Tao-Hua Liu; Qi-Quan Wan
Journal:  Proteome Sci       Date:  2022-06-09       Impact factor: 2.882

5.  Immune profiling of pituitary tumors reveals variations in immune infiltration and checkpoint molecule expression.

Authors:  Yu Mei; Wenya Linda Bi; James Agolia; Changchen Hu; Alexandra M Giantini Larsen; David M Meredith; Sally Al Abdulmohsen; Tejus Bale; Gavin P Dunn; Malak Abedalthagafi; Ian F Dunn
Journal:  Pituitary       Date:  2021-01-25       Impact factor: 4.107

6.  Comprehensive analysis of N6-methyladenosine regulators with the tumor immune landscape and correlation between the insulin-like growth factor 2 mRNA-binding protein 3 and programmed death ligand 1 in bladder cancer.

Authors:  Jianfeng Cui; Yaofeng Zhu; Xiaochen Liu; Wenfu Wang; Xuewen Jiang; Yangyang Xia; Guanwen Zhou; Shouzhen Chen; Benkang Shi
Journal:  Cancer Cell Int       Date:  2022-02-11       Impact factor: 5.722

Review 7.  Phosphatase and Tensin Homolog in Non-neoplastic Digestive Disease: More Than Just Tumor Suppressor.

Authors:  Tianyu He; Xiaoyun Zhang; Jianyu Hao; Shigang Ding
Journal:  Front Physiol       Date:  2021-06-01       Impact factor: 4.566

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.